Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneva (AZN) Announces License Agreement with TerSera Therapeutics for U.S and Canadian Commercial Rights to Zoladex in Prostate Cancer, Breast Cancer, and Certain Gynecological Disorders

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
TerSera Therapeutics


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Feb 21, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords License Agreement, Zoladex, Prostate Cancer, Breast Cancer, Gynecological Disorders